Literature DB >> 30571201

Outcomes Following Percutaneous Coronary Intervention in Non-ST-Segment-Elevation Myocardial Infarction Patients With Coronary Artery Bypass Grafts.

Ahmad Shoaib1, Tim Kinnaird2, Nick Curzen3, Evangelos Kontopantelis4, Peter Ludman5, Mark de Belder6, Muhammad Rashid1, Chun Shing Kwok1, James Nolan1, Azfar Zaman7, Mamas A Mamas1.   

Abstract

Background There are limited data on outcomes of patients with previous coronary artery bypass graft (CABG) presenting with non-ST-segment-elevation myocardial infarction undergoing percutaneous coronary intervention (PCI). We compare clinical characteristics and outcomes in non-ST-segment-elevation myocardial infarction patients undergoing PCI with or without prior CABG surgery in a national cohort. Methods and Results We identified 205 039 patients with non-ST-segment-elevation myocardial infarction who underwent PCI between 2007 and 2014 in the British Cardiovascular Intervention Society database. Clinical, demographic, procedural, and outcome data were analyzed by dividing into 3 groups: group 1, PCI in native coronary arteries and no prior CABG (n=186 670); group 2, PCI in native arteries with prior CABG (n=8825); group 3, PCI in grafts (n=9544). Patients in group 2 and 3 were older and had more comorbidities and higher mortality at 30 days (group 2, 2.6% and group 3, 1.9%) and 1 year (group 2, 8.29% and group 3, 7.08%) as compared with group 1 (1.7% and 4.87%). After multivariable analysis, no significant difference in outcomes was observed in 30-days mortality (odds ratio; group 2=0.87 [CI, 0.69-1.80; P=0.20], group 3=0.91 [CI, 0.71-1.17; P=0.46]), in-hospital major adverse cardiovascular event (odds ratio: group 2=1.08 [CI, 0.88-1.34; P=0.45], group 3=0.97 [CI=0.77-1.23; P=0.82]), and in-hospital stroke (odds ratio: group 2=1.37 [CI, 0.71-2.69; P=0.35], group 3=1.13 [CI, 0.55-2.34; P=0.73]; group 1=reference). Conclusions Patients with prior CABG are presenting with non-ST-segment-elevation myocardial infarction and treated with PCI had more comorbid illnesses, but once these differences were adjusted for, prior CABG did not independently confer additional risk of mortality and major adverse cardiovascular event.

Entities:  

Keywords:  comorbidity; coronary artery disease; mortality; myocardial infarction; percutaneous coronary intervention

Mesh:

Year:  2018        PMID: 30571201     DOI: 10.1161/CIRCINTERVENTIONS.118.006824

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  2 in total

1.  Invasive Versus Medical Management in Patients With Prior Coronary Artery Bypass Surgery With a Non-ST Segment Elevation Acute Coronary Syndrome.

Authors:  Matthew M Y Lee; Mark C Petrie; Paul Rocchiccioli; Joanne Simpson; Colette E Jackson; David S Corcoran; Kenneth Mangion; Ammani Brown; Pio Cialdella; Novalia P Sidik; Margaret B McEntegart; Aadil Shaukat; Alan P Rae; Stuart H M Hood; Eileen E Peat; Iain N Findlay; Clare L Murphy; Alistair J Cormack; Nikolay B Bukov; Kanarath P Balachandran; Keith G Oldroyd; Ian Ford; Olivia Wu; Alex McConnachie; Sarah J E Barry; Colin Berry
Journal:  Circ Cardiovasc Interv       Date:  2019-07-31       Impact factor: 6.546

2.  Invasive versus medically managed acute coronary syndromes with prior bypass (CABG-ACS): insights into the registry versus randomised trial populations.

Authors:  Matthew M Y Lee; Mark C Petrie; Paul Rocchiccioli; Joanne Simpson; Colette E Jackson; David S Corcoran; Kenneth Mangion; Ammani Brown; Pio Cialdella; Novalia P Sidik; Margaret B McEntegart; Aadil Shaukat; Alan P Rae; Stuart H M Hood; Eileen E Peat; Iain N Findlay; Clare L Murphy; Alistair J Cormack; Nikolay B Bukov; Kanarath P Balachandran; Ian Ford; Olivia Wu; Alex McConnachie; Sarah J E Barry; Colin Berry
Journal:  Open Heart       Date:  2021-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.